DocGo Statistics
Total Valuation
DocGo has a market cap or net worth of $102.70 million. The enterprise value is $58.81 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DocGo has 97.81 million shares outstanding. The number of shares has decreased by -7.55% in one year.
| Current Share Class | 97.81M |
| Shares Outstanding | 97.81M |
| Shares Change (YoY) | -7.55% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 7.33% |
| Owned by Institutions (%) | 52.05% |
| Float | 90.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.29 |
| Forward PS | 0.35 |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | 1.91 |
| P/OCF Ratio | 1.78 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.09 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.59 |
| Quick Ratio | 2.45 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.55 |
| Interest Coverage | -24.34 |
Financial Efficiency
Return on equity (ROE) is -21.06% and return on invested capital (ROIC) is -11.94%.
| Return on Equity (ROE) | -21.06% |
| Return on Assets (ROA) | -9.47% |
| Return on Invested Capital (ROIC) | -11.94% |
| Return on Capital Employed (ROCE) | -22.91% |
| Revenue Per Employee | $83,525 |
| Profits Per Employee | -$11,707 |
| Employee Count | 4,407 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -20.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks. The beta is 0.93, so DocGo's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 49.33 |
| Average Volume (20 Days) | 840,453 |
Short Selling Information
The latest short interest is 4.22 million, so 4.32% of the outstanding shares have been sold short.
| Short Interest | 4.22M |
| Short Previous Month | 4.40M |
| Short % of Shares Out | 4.32% |
| Short % of Float | 4.66% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
In the last 12 months, DocGo had revenue of $368.09 million and -$51.59 million in losses. Loss per share was -$0.53.
| Revenue | 368.09M |
| Gross Profit | 114.89M |
| Operating Income | -64.19M |
| Pretax Income | -82.46M |
| Net Income | -51.59M |
| EBITDA | -49.15M |
| EBIT | -64.19M |
| Loss Per Share | -$0.53 |
Full Income Statement Balance Sheet
The company has $73.36 million in cash and $29.46 million in debt, giving a net cash position of $43.89 million or $0.45 per share.
| Cash & Cash Equivalents | 73.36M |
| Total Debt | 29.46M |
| Net Cash | 43.89M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 260.66M |
| Book Value Per Share | 2.77 |
| Working Capital | 116.64M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $57.86 million and capital expenditures -$3.99 million, giving a free cash flow of $53.87 million.
| Operating Cash Flow | 57.86M |
| Capital Expenditures | -3.99M |
| Free Cash Flow | 53.87M |
| FCF Per Share | $0.55 |
Full Cash Flow Statement Margins
Gross margin is 31.21%, with operating and profit margins of -17.44% and -14.02%.
| Gross Margin | 31.21% |
| Operating Margin | -17.44% |
| Pretax Margin | -22.40% |
| Profit Margin | -14.02% |
| EBITDA Margin | -13.35% |
| EBIT Margin | -17.44% |
| FCF Margin | 14.63% |
Dividends & Yields
DocGo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.55% |
| Shareholder Yield | 7.55% |
| Earnings Yield | -50.23% |
| FCF Yield | 52.45% |
Analyst Forecast
The average price target for DocGo is $3.33, which is 217.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.33 |
| Price Target Difference | 217.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DocGo has an Altman Z-Score of 2.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 3 |